Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02072746 · ClinicalTrials.gov registry record · NA
Zinc Supplementation in Alcoholic Cirrhosis
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02072746 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 30 participants.
The verdict
NCT02072746, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if zinc therapy: (1) strengthens your intestine's defensive barrier preventing damaging substances from reaching your liver, (2) decreases liver injury (inflammation, oxidative stress, cell death) and scarring, and (3) improves your liver-related health. Based on our preliminary animal data and other published reports, we expect zinc therapy to achieve all of these goals. Zinc is affordable, available over the counter or by prescription, and has an excellent safety profile. Positive results from this study will show that zinc is a significant therapy for millions of Americans with alcoholic liver disease.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Zinc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2010-02 |
| Est. Completion | 2019-03-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02072746
The ClinicalTrials.gov registry entry for NCT02072746 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02072746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02072746 about?
NCT02072746 is a clinical study titled "Zinc Supplementation in Alcoholic Cirrhosis". The purpose of this study is to determine if zinc therapy: (1) strengthens your intestine's defensive barrier preventing damaging substances from reaching your liver, (2) decreases liver injury (inflammation, oxidative stress, cell death) and scarring, and (3) improves your liver-related health. Bas...
What is the current status of trial NCT02072746?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2010-02. Estimated completion is 2019-03-01.
What interventions are being tested in trial NCT02072746?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Zinc (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02072746?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.